Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Gross Profit: 2010-2018

Historic Gross Profit for EyePoint Pharmaceuticals (EYPT) over the last 9 years, with Jun 2018 value amounting to $1.4 million.

  • EyePoint Pharmaceuticals' Gross Profit fell 920.78% to -$3.2 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$1.4 million, marking a year-over-year decrease of 118.53%. This contributed to the annual value of $1.4 million for FY2018, which is 80.78% down from last year.
  • As of FY2018, EyePoint Pharmaceuticals' Gross Profit stood at $1.4 million, which was down 80.78% from $7.5 million recorded in FY2017.
  • EyePoint Pharmaceuticals' Gross Profit's 5-year high stood at $26.6 million during FY2015, with a 5-year trough of $1.4 million in FY2018.
  • In the last 3 years, EyePoint Pharmaceuticals' Gross Profit had a median value of $1.6 million in 2016 and averaged $3.5 million.
  • Its Gross Profit has fluctuated over the past 5 years, first surged by 664.90% in 2015, then slumped by 93.90% in 2016.
  • EyePoint Pharmaceuticals' Gross Profit (Yearly) stood at $3.5 million in 2014, then soared by 664.90% to $26.6 million in 2015, then slumped by 93.90% to $1.6 million in 2016, then skyrocketed by 365.37% to $7.5 million in 2017, then slumped by 80.78% to $1.4 million in 2018.